Nudge
CompanyAnnouncing our $100M Series A Led by Thrive Capital and Greenoaks
About half of all people will experience a neurological or psychiatric disorder in their lifetime.1 While we’ve made significant advances in treating infectious diseases, cancer, and cardiovascular conditions, progress in brain health has lagged far behind. These disorders, like addiction, chr
Date
Jul 22, 2025
Category
biotech
Lead investor
Thrive Capital
Stage
Series A
Size
$100M
Valor Equity Partners
Greycroft
Kindred Ventures
General Catalyst
Kleiner Perkins
Pelion Venture Partners
Khosla Ventures
Benchmark
Point Nine
Accel
SoftBank Vision Fund